2014•Transplantation and Cellular TherapyOpen access

Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Myelodysplastic Syndrome (MDS): A Single Center Experience

Virginina Abello, Licet Villamizar, Enrique Pedraza, Carmen Rosales, Manuel Rosales, Javier Figueroa, Iris Córdoba, Herman Esguerra

Open full text 0 citations

Abstract

HSCT is the only potentially curative therapy for a well-selected group of patients with MDS. The objective of this work was to describe a single center experience over the past 15 years with HSCT in MDS patients.

About this research paper

What this paper is about

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Medicine, Single Center, Hematopoietic stem cell transplantation, Myelodysplastic syndromes, Transplantation, Stem cell, Hematopoietic cell, Center (category theory)